LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 138

Search options

  1. Book: Expertise Allgemein- und Viszeralchirurgie Leber und Gallenwege

    Aselmann, Heiko / Bechstein, Wolf Otto / Schnitzbauer, Andreas A.

    (Expertise Allgemein- und Viszeralchirurgie)

    2018  

    Title variant Leber und Gallenwege ; Expertise Allgemein- und Viszeralchirurgie
    Author's details herausgegeben von Wolf Otto Bechstein, Andreas Anton Schnitzbauer ; mit Beiträgen von Heiko Aselmann [und weiteren]
    Series title Expertise Allgemein- und Viszeralchirurgie
    Keywords Leberkrankheit ; Leberchirurgie ; Gallenwegskrankheit ; Gallenwegschirurgie
    Subject Gallenwege ; Leber ; Lebererkrankung ; Hepatopathie ; Hepatopathia
    Language German
    Size 213 Seiten, Illustrationen, 31 cm x 23 cm
    Publisher Georg Thieme Verlag
    Publishing place Stuttgart ; New York
    Publishing country Germany
    Document type Book
    Note Zugang zur Online-Ausgabe über Code
    HBZ-ID HT019345930
    ISBN 978-3-13-200871-7 ; 3-13-200871-0 ; 9783132008816 ; 9783132008915 ; 3132008818 ; 3132008915
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Step hunting!-how fitness apps and electronic feedback devices enter our lives.

    Schnitzbauer, Andreas A

    Transplant international : official journal of the European Society for Organ Transplantation

    2020  Volume 33, Issue 6, Page(s) 615–616

    MeSH term(s) Electronics ; Exercise ; Feedback ; Humans ; Software
    Language English
    Publishing date 2020-02-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 639435-8
    ISSN 1432-2277 ; 0934-0874
    ISSN (online) 1432-2277
    ISSN 0934-0874
    DOI 10.1111/tri.13594
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Digital prehabilitation-a solution to resource shortages?

    Schnitzbauer, Andreas A / Zmuc, Dora / Fleckenstein, Johannes

    The Lancet. Digital health

    2023  Volume 6, Issue 1, Page(s) e11

    MeSH term(s) Humans ; Preoperative Exercise ; Postoperative Complications
    Language English
    Publishing date 2023-12-20
    Publishing country England
    Document type Letter
    ISSN 2589-7500
    ISSN (online) 2589-7500
    DOI 10.1016/S2589-7500(23)00247-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Diagnosis and Treatment of Ampullary Carcinoma.

    Walter, Dirk / Schnitzbauer, Andreas A / Schulze, Falko / Trojan, Jörg

    Deutsches Arzteblatt international

    2023  Volume 120, Issue 43, Page(s) 729–735

    Abstract: Background: Ampullary or papillary carcinoma is a malignant tumor arising from the mucosa in the region of the major duodenal papilla, also known as the ampulla of Vater. Uniform treatment recommendations are lacking both for the adjuvant situation and ... ...

    Abstract Background: Ampullary or papillary carcinoma is a malignant tumor arising from the mucosa in the region of the major duodenal papilla, also known as the ampulla of Vater. Uniform treatment recommendations are lacking both for the adjuvant situation and for palliative care.
    Methods: A selective literature search was carried out in PubMed in order to identify the most informative publications concerning the epidemiology, clinico-pathological background, and surgical and medical treatment of this condition.
    Results: Ampullary carcinoma has an incidence of 0.5 to 0.9 per 100 000 persons and a poor prognosis, with a 5-year survival rate of 41% to 45% for locally confined and 4% to 7% for metastatic disease. Most such tumors are of an intestinal or a pan - creaticobiliary immunohistochemical subtype; the latter has a worse prognosis (median survival, 72-80 vs. 33-41 months). Targeted treatment is not yet available for either subtype, nor is there enough scientific evidence available for the formulation of specific therapeutic recommendations in either the adjuvant or the palliative situation. The treatment of choice for ampullary carcinoma is radical oncological resection of the head of the pancreas with systematic lymphadenectomy. Five-year overall survival is between 10% and 75% depending on the stage. No definitive recommendation for adjuvant therapy can be given. Palliative therapy can be oriented to the published treatment strategies for cancer of the colon, pancreas, and bile duct.
    Conclusion: The current state of the evidence on the treatment of ampullary carcinoma is poor. Therapeutic decisions should be discussed in an interdisciplinary tumor board and should, in our opinion, take the histological subtype into account.
    MeSH term(s) Humans ; Ampulla of Vater/pathology ; Ampulla of Vater/surgery ; Adenocarcinoma/pathology ; Prognosis ; Pancreatic Neoplasms/surgery ; Combined Modality Therapy
    Language English
    Publishing date 2023-09-01
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2406159-1
    ISSN 1866-0452 ; 1866-0452
    ISSN (online) 1866-0452
    ISSN 1866-0452
    DOI 10.3238/arztebl.m2023.0195
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: A Comparison of Pitfalls after ALPPS Stage 1 or Portal Vein Embolization in Small-for-Size Setting Hepatectomies.

    Schnitzbauer, Andreas A

    Visceral medicine

    2017  Volume 33, Issue 6, Page(s) 435–441

    Abstract: Background: Portal vein embolization (PVE) followed by resection and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) are tools to enable liver resections in small-for-size settings.: Methods: A systematic review of ...

    Abstract Background: Portal vein embolization (PVE) followed by resection and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) are tools to enable liver resections in small-for-size settings.
    Methods: A systematic review of the literature and comparison of pitfalls between PVE and resection and after ALPPS stage 1 were performed.
    Results: Evidence levels were as low as 4 for both procedures. 20 publications were identified with reports on post-PVE or post-ALPPS stage 1 pitfalls. A total of 2,758 patients treated with PVE followed by resection and 698 patients undergoing ALPPS were analyzed. Pitfalls identified were failure to advance to resection (PVE: high (20%)/ALPPS: low (1%); p = 0.0001), tumor progression (PVE: high/ALPPS: low); insufficient hypertrophy (PVE: frequent/ALPPS: rare), and inter-stage liver failure (PVE: rare/ALPPS: frequent). However, in-house mortality was still very high after ALPPS (7 vs. 3%, p = 0.0001) in a pooled analysis.
    Conclusion: PVE is a well-established technique to induce hypertrophy in small-for-size settings. The weakness of PVE is that it may fail to advance to resection. Inter-stage liver failure in ALPPS triggers post-stage 2 mortality. Prolongation of the inter-stage interval to overcome liver failure or cancellation of the resection stage combined with adherence to defined indications has the potential to make ALPPS much safer and decrease mortality rates. Level of evidence is low for both techniques.
    Language English
    Publishing date 2017-12-04
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2850733-2
    ISSN 2297-475X ; 2297-4725
    ISSN (online) 2297-475X
    ISSN 2297-4725
    DOI 10.1159/000480100
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure.

    Schulz, Martin S / Gu, Wenyi / Schnitzbauer, Andreas A / Trebicka, Jonel

    Transplant international : official journal of the European Society for Organ Transplantation

    2022  Volume 35, Page(s) 10108

    Abstract: Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver ... ...

    Abstract Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.
    MeSH term(s) Acute-On-Chronic Liver Failure/surgery ; Humans ; Liver Cirrhosis ; Liver Transplantation ; Prognosis ; Waiting Lists
    Language English
    Publishing date 2022-03-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 639435-8
    ISSN 1432-2277 ; 0934-0874
    ISSN (online) 1432-2277
    ISSN 0934-0874
    DOI 10.3389/ti.2022.10108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Operative Procedures: New Ways of Managing Frailty.

    Bechstein, Wolf O / Schnitzbauer, Andreas A

    Deutsches Arzteblatt international

    2019  Volume 116, Issue 5, Page(s) 61–62

    MeSH term(s) Frailty/surgery ; Humans
    Language English
    Publishing date 2019-04-08
    Publishing country Germany
    Document type Editorial
    ZDB-ID 2406159-1
    ISSN 1866-0452 ; 1866-0452
    ISSN (online) 1866-0452
    ISSN 1866-0452
    DOI 10.3238/arztebl.2019.0061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: [No title information]

    D'Haese, Jan G / Uhl, Waldemar / Schnitzbauer, Andreas A / Hoffmann, Katrin / Stavrou, Gregor A

    Chirurgie (Heidelberg, Germany)

    2023  Volume 94, Issue 7, Page(s) 664

    Title translation Erratum zu: Potenzielle Patientengefährdung durch Produktionsstopp klassischer T‑Drainagen?
    Language German
    Publishing date 2023-06-29
    Publishing country Germany
    Document type Published Erratum
    ISSN 2731-698X
    ISSN (online) 2731-698X
    DOI 10.1007/s00104-023-01889-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Potenzielle Patientengefährdung durch Produktionsstopp klassischer T-Drainagen? : Deutschlandweite Umfrage und Stellungnahme der Chirurgischen Arbeitsgemeinschaft für Leber‑, Galle- und Pankreaserkrankungen (CALGP) der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV).

    D'Haese, Jan G / Uhl, Waldemar / Schnitzbauer, Andreas A / Hoffmann, Katrin / Stavrou, Gregor A

    Chirurgie (Heidelberg, Germany)

    2023  Volume 94, Issue 5, Page(s) 419–423

    Abstract: The revision of the medical device regulation (MDR) legislation by the European Union and supplementations by the member states has been implemented for good reasons but causes dramatic side effects. It is no longer allowed to produce some rarely used ... ...

    Title translation Potential risk to patient safety by discontinuation of production of classical T-drains? : Nationwide survey in Germany and statement of the surgical working group for liver, gall bladder and pancreatic diseases (CALGP) of the German Society for General and Visceral Surgery (DGAV).
    Abstract The revision of the medical device regulation (MDR) legislation by the European Union and supplementations by the member states has been implemented for good reasons but causes dramatic side effects. It is no longer allowed to produce some rarely used medical devices by various manufacturers that have been successfully used for decades. Before production, a new application to the MDR would be necessary, which is not a realistic business case for companies producing rarely used devices. This problem currently relates to the Kehr T‑drain made from soft rubber or latex that has been in use since the late nineteenth century. A surgically placed T‑drain, although rarely necessary nowadays, is still in use worldwide for special indications in an attempt to avoid severe complications. These special indications include complex hepato-pancreato-biliary (HPB) procedures and perforations of the upper gastrointestinal (GI) tract where T‑drains may be used to secure the hepatojejunostomy or to create a stable fistula. The HPB working group (CALGP) of the German Society of General and Visceral Surgery (DGAV) provides a statement from a surgical perspective on this matter after a survey of all its members. Politics should be very careful not to generalize when implementing useful new regulations at a European and national level. Established and comprehensible treatment concepts should not be restricted and exemption permits should be quickly granted in these cases because the discontinuation of these niche products may lead to potential patient safety issues and even fatalities.
    MeSH term(s) Humans ; Gallbladder ; Patient Safety ; Liver ; Pancreatic Diseases ; Societies, Medical ; Germany
    Language German
    Publishing date 2023-04-18
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-698X
    ISSN (online) 2731-698X
    DOI 10.1007/s00104-023-01851-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Influence of aberrant right hepatic artery on survival after pancreatic resection for ductal adenocarcinoma of the pancreatic head.

    Petrova, Ekaterina / Mazzella, Elena / Eichler, Katrin / Gruber-Rouh, Tatjana / Schulze, Falko / Bechstein, Wolf O / Schnitzbauer, Andreas A

    Langenbeck's archives of surgery

    2024  Volume 409, Issue 1, Page(s) 111

    Abstract: Purpose: The presence of an aberrant right hepatic artery (aRHA), arising from the superior mesenteric artery, is a common variant of the liver vascular anatomy. Considering that tumor spread occurs along vessels, the question arises, whether the ... ...

    Abstract Purpose: The presence of an aberrant right hepatic artery (aRHA), arising from the superior mesenteric artery, is a common variant of the liver vascular anatomy. Considering that tumor spread occurs along vessels, the question arises, whether the presence of an aRHA influences the oncologic outcome after resection for cancer of the pancreatic head.
    Methods: Patients with ductal adenocarcinoma of the pancreatic head, who underwent resection from 2011 to 2020 at the Frankfurt University Hospital, Germany, were analyzed retrospectively. Surgical records and computed tomography imaging were reviewed for the presence of aRHA. Overall and disease-free survival as well as hepatic recurrence were analyzed according to the presence of aRHA.
    Results: aRHA was detected in 21 out of 145 patients (14.5%). The median overall survival was 26 months (95%CI 20.8-34.4), median disease-free survival was 12.1 months (95%CI 8.1-17.3). There was no significant difference in overall survival (26.1 versus 21.4 months, adjusted hazard ratio 1.31, 95%CI 0.7-2.46, p = 0.401) or disease-free survival (14.5 months versus 12 months, adjusted hazard ratio 0.98, 95%CI 0.57-1.71, p = 0.957) without and with aRHA. The hepatic recurrence rate was 24.4.% with conventional anatomy versus 30.8% with aRHA (adjusted odds ratio 1.36, 95%CI 0.3-5.38, p = 0.669). In the multivariable analysis, only lymphatic vessel invasion was an independent prognostic factor for hepatic recurrence.
    Conclusions: The presence of an aRHA does not seem to influence the long-term survival and hepatic recurrence after resection for ductal adenocarcinoma of the pancreatic head.
    MeSH term(s) Humans ; Hepatic Artery/surgery ; Retrospective Studies ; Pancreas ; Pancreatectomy ; Adenocarcinoma
    Language English
    Publishing date 2024-04-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1423681-3
    ISSN 1435-2451 ; 1435-2443
    ISSN (online) 1435-2451
    ISSN 1435-2443
    DOI 10.1007/s00423-024-03296-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top